Relevance of MICA and other non-HLA antibodies in clinical transplantation

Current Opinion in Immunology

Volumn 20, Issue 5, 2008, Pages 607-613

  Sumitran Holgersson, Suchitra ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOANTIGEN; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; HLA ANTIBODY; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1BETA; INTERLEUKIN 8; MAJOR HISTOCOMPATIBILITY ANTIGEN; MHC CLASS I RELATED CHAIN A; MHC CLASS I RELATED CHAIN B; PADGEM PROTEIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE 1;

ACUTE GRAFT REJECTION; ANTIBODY RESPONSE; ANTIBODY SPECIFICITY; ANTIGEN EXPRESSION; BINDING AFFINITY; CELLULAR IMMUNITY; CHRONIC GRAFT REJECTION; ENDOTHELIUM CELL; GENETIC POLYMORPHISM; GRAFT REJECTION; HEART TRANSPLANTATION; HUMAN; HYPERACUTE GRAFT REJECTION; IMMUNE RESPONSE; IMMUNOMODULATION; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; ORGAN TRANSPLANTATION; OUTCOME ASSESSMENT; PATHOGENESIS; PATHOGENICITY; PROGNOSIS; RECIPIENT; REVIEW; TARGET CELL;

ENDOTHELIAL CELLS; GRAFT REJECTION; HISTOCOMPATIBILITY ANTIGENS CLASS I; HLA ANTIGENS; HUMANS; ISOANTIBODIES; MONOCYTES; ORGAN TRANSPLANTATION;

EID: 50549091700     PISSN: 09527915     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.coi.2008.07.005     Document Type: Review

References (58)

1. Sheldon S., and Poulton K. HLA typing and its influence on organ transplantation. Methods Mol Biol 333 (2006) 157-174
2. Cecka J.M., Zhang Q., and Reed E.F. Preformed cytotoxic antibodies in potential allograft recipients: recent data. Human Immunol 66 (2005) 343-349
3. Zachary A.A., Montgomery R.A., Jordan S.C., Reinsmoen N.L., Claas F.H., and Reed E.F. 14th International HLA and immunogenetics workshop: report on understanding antibodies in transplantation. Tissue Antigens 69 (2007) 160-173. An excellent and comprehensive review of the importance of antibodies, new immunosuppressive agents and progressive treatment protocols in the highly immunized patients.
4. Brasile L., Rodman E., Shield III C.F., Clarke J., and Cerilli J. The association of antivascular endothelial cell antibody with hyperacute rejection: a case report. Surgery 99 (1986) 637-640
5. Sumitran-Karuppan S., Tyden G., Reinholt F., Berg U., and Moller E. Hyperacute rejections of two consecutive renal allografts and early loss of the third transplant caused by non-HLA antibodies specific for endothelial cells. Transpl Immunol 5 (1997) 321-327
6. Perrey C., Brenchley P.E., Johnson R.W., and Martin S. An association between antibodies specific for endothelial cells and renal transplant failure. Transpl Immunol 6 (1998) 101-106
7. Faulk W.P., Rose M., Meroni P.L., Del Papa N., Torry R.J., Labarrere C.A., Busing K., Crisp S.J., Dunn M.J., and Nelson D.R. Antibodies to endothelial cells identify myocardial damage and predict development of coronary artery disease in patients with transplanted hearts. Hum Immunol 60 (1999) 826-832
8. Crisp S.J., Dunn M.J., Rose M.L., Barbir M., and Yacoub M.H. Antiendothelial antibodies after heart transplantation: the accelerating factor in transplant-associated coronary artery disease?. J Heart Lung Transplant 13 (1994) 81-91-82
9. Brasile L., Zerbe T., Rabin B., Clarke J., Abrams A., and Cerilli J. Identification of the antibody to vascular endothelial cells in patients undergoing cardiac transplantation. Transplantation 40 (1985) 672-675
10. Erlich H.A., Opelz G., and Hansen J. HLA DNA typing and transplantation. Immunity 14 (2001) 347-356
11. Race R.R., and Sanger R. Blood Groups in Man (1958), Blackwell Science, Oxford
12. Kayler L.K., Farber J.L., Colombe B., LaCava D., Friedewald J.J., and Ratner L.E. Characterization of rejection episodes in patients following positive crossmatch and ABO-incompatible live donor renal transplantation. Transpl Int 19 (2006) 128-139
13. Terasaki P.I. Deduction of the fraction of immunologic and non-immunologic failure in cadaver donor transplants. In: Cecka J.M., and Terasaki P.I. (Eds). Clinical Transplants (2003), UCLA Tissue Typing Laboratory, Los Angeles, CA 449-452. A meticulously performed study demonstrating the degree to which HLA, non-HLA and nonimmunological factors play a role in organ graft loss.
14. Derhaag J.G., Duijvestijn A.M., Damoiseaux J.G., and van Breda Vriesman P.J. Effects of antibody reactivity to major histocompatibity complex (MHC) and non-MHC alloantigens on graft endothelial cells in heart allograft rejection. Transplantation 69 (2000) 1899-1906
15. Wu G.D., Jin Y.S., Salazar R., Dai W.D., Barteneva N., Barr M.L., Barsky L.W., Starnes V.A., and Cramer D.V. Vascular endothelial cell apoptosis induced by anti-donor non-MHC antibodies: a possible injury pathway contributing to chronic allograft rejection. J Heart Lung Transplant 21 (2002) 1174-1187
16. Gruber S., Dehlink E., Eiwegger T., Gut S., Jaksch P., Klepetko W., Rumpold H., and Szépfalusi Z. Immunoglobulin E-mediated allergies in lung-transplanted adults. Transplantation 84 (2007) 275-279
17. Tinckam K.J., and Chandraker A. Mechanisms and role of HLA and non-HLA alloantibodies. Clin J Am Soc Nephrol 1 (2006) 404-414. A comprehensive review of the important role of alloantibodies.
18. Mahesh B., Leong H.S., McCormack A., Sarathchandra P., Holder A., and Rose M.L. Autoantibodies to vimentin cause accelerated rejection of cardiac allografts. Am J Pathol 170 (2007) 1415-1427. A well-performed study providing evidence for the importance of the non-HLA antigen vimentin in heart transplants.
19. Otten H.G., van den Bosch J.M., van Ginkel W.G., van Loon M., and van de Graaf E.A. Identification of non-HLA target antigens recognized after lung transplantation. J Heart Lung Transplant 25 (2006) 1425-1430. An interesting article describing a method for the identification of non-HLA antigens that may play a role in lung transplant rejections.
20. Brooks-Worrell B.M., Peterson K.P., Peterson C.M., Palmer J.P., and Jovanovic L. Reactivation of type 1 diabetes in patients receiving human fetal pancreatic tissue transplants without immunosuppression. Transplantation 69 (2000) 166-172
21. Grandtnerova B., Laca L., Jahnova E., et al. Hyperacute rejection of living related kidney graft caused by IgG endothelial specific antibodies with a negative monocyte cross-match. Ann Transplant 7 (2002) 52-54
22. Sumitran-Holgersson S., Karrar A., Ge X., Xu B., Nava S., Broomé U., Nowak G., and Ericzon B.G. A novel mechanism of liver allograft rejections facilitated by antibodies to liver sinusoidal endothelial cells. Hepatology 40 (2004) 1211-1221
23. Claas F.H., Paul L.C., van Es L.A., and van Rood J.J. Antibodies against donor antigens on endothelial cells and monocytes in eluates of rejected kidney allografts. Tissue Antigens 15 (1980) 19-24
24. Opelz G., and Collaborative Transplant Study. Non-HLA transplantation immunity revealed by lymphocytotoxic antibodies. Lancet 365 (2005) 1570-1576. This very interesting study suggests a role for non-HLA immunity in chronic graft loss.
25. Rose M.L. Long-term effects of damage to the endothelium and chronic rejection. J Heart Lung Transplant 23 (2004) S240-S243
26. Dubel L., Farges O., Johanet C., Sebagh M., and Bismuth H. High incidence of anti-tissue antibodies in patients experiencing chronic liver allograft rejection. Transplantation 65 (1998) 1072-1075
27. Sumitran-Holgersson S., Ge X., Karrar A., Xu B., Nava S., Broomé U., Nowak G., and Ericzon B.G. Antibodies to liver sinusoidal endothelial cells modulate immune responses in liver transplantation. Transplant Proc 37 (2005) 3335-3337
28. Ge X., Uzunel M., Ericzon B.G., and Sumitran-Holgersson S. Are preformed antibodies to biliary epithelial cells of clinical importance in liver transplantation?. Liver Transpl 9 (2003) 1191-1198
29. Ge X., Uzunel M., Ericzon B.G., and Sumitran-Holgersson S. Biliary epithelial cell antibodies induce expression of toll-like receptors 2 and 3: a mechanism for post-liver transplant cholangitis?. Liver Transpl 11 (2005) 911-921
30. Rhodes C.L., Goldman M.H., Mendez-Picon G., Lee H.M., and Mohanakumar T. Multiple specificities of B lymphocyte-reactive antibodies and their significance in renal allograft survival. Transplant Proc 16 (1984) 1425-1426
31. Taylor C.J., Chapman J.R., Ting A., and Morris P.J. Characterization of lymphocytotoxic antibodies causing a positive crossmatch in renal transplantation. Relationship to primary and regraft outcome. Transplantation 48 (1989) 953-958
32. Carter V., Shenton B.K., Jaques B., Turner D., Talbot D., Gupta A., Chapman C.E., Matthews C.J., and Cavanagh G. Vimentin antibodies: a non-HLA antibody as a potential risk factor in renal transplantation. Transplant Proc 37 (2005) 654-657
33. Jurcevic S., Ainsworth M.E., Pomerance A., Smith J.D., Robinson D.R., Dunn M.J., Yacoub M.H., and Rose M.L. Anti-vimentin antibodies are an independent predictor of transplant-associated coronary artery disease after cardiac transplantation. Transplantation 71 (2001) 886-892
34. Kekomäki S., Kyllönen L., Salmela K., Koskimies S., and Kekomäki R. Platelet-specific alloantigens in cadaveric renal transplantation: a prospective study: effect of HPA-5b mismatch in acute vascular rejection of renal allografts. Tissue Antigens 57 (2001) 154-157
35. Tinckam K., Rush D., Hutchinson I., Dembinski I., Pravica V., Jeffery J., and Nickerson P. The relative importance of cytokine gene polymorphisms in the development of early and late acute rejection and six-month renal allograft pathology. Transplantation 79 (2005) 836-841
36. Abdi R., Tran T.B., Sahagun-Ruiz A., Murphy P.M., Brenner B.M., Milford E.L., and McDermott D.H. Chemokine receptor polymorphism and risk of acute rejection in human renal transplantation. J Am Soc Nephrol 13 (2002) 754-758
37. Nakano T., Goto S., Lai C.Y., Hsu L.W., Kao Y.H., Lin Y.C., Kawamoto S., Chiang K.C., Ohmori N., Goto T., et al. Experimental and clinical significance of antinuclear antibodies in liver transplantation. Transplantation 83 (2007) 1122-1125
38. Jennette J.C., and Falk R.J. New insight into the pathogenesis of vasculitis associated with antineutrophil cytoplasmic autoantibodies. Curr Opin Rhuematol 20 (2008) 55-60
39. Joosten S.A., Sijpkens Y.W., van Ham V., Trouw L.A., van der Vlag J., van den Heuvel B., van Kooten C., and PaulF L.C. Antibody response against the glomerular basement membrane protein agrin in patients with transplant glomerulopathy. Am J Transplant 5 (2005) 383-393. This study identifies a humoral response against a non-HLA tissue-specific autoantigen, agrin associated with graft rejections.
40. Dragun D., Müller D.N., Bräsen J.H., Fritsche L., Nieminen-Kelhä M., Dechend R., Kintscher U., Rudolph B., Hoebeke J., Eckert D., et al. Angiotensin II type 1-receptor activating antibodies in renal-allograft rejection. N Engl J Med 352 (2005) 558-569. This study demonstrates that non-HLA Abs too can be pathogenic. Passive antibody transfer induced vasculopathy and hypertension in a rat kidney-transplantation model.
41. Lucq J., Tixier D., Guinault A.M., Greffard A., Loisance D., and Pilatte Y. The target antigens of naturally occurring human anti-beta-galactose IgG are cryptic on porcine aortic endothelial cells. Xenotransplantation 7 (2000) 3
42. Bahram S., Bresnahan M., Geraghty D.E., and Spies T. A second lineage of mammalian major histocompatibility complex class I genes. Proc Natl Acad Sci U S A 91 (1994) 6259-6263
43. Zwirner N.W., Dole K., and Stastny P. Differential surface expression of MICA by endothelial cells, fibroblasts, keratinocytes, and monocytes. Human Immunol 60 (1999) 323-330
44. Zwirner N.W., Marcos C.Y., Mirbaha F., Zou Y., and Stastny P. Identification of MICA as a new polymorphic alloantigen recognized by antibodies in sera of organ transplant recipients. Human Immunol 61 (2000) 917-924. This study for the first time demonstrated that polymorphic, MICA molecules are expressed at the cell surface of endothelial cells and may thus act as target molecules for antibodies in allograft rejection.
45. Stastny P. Introduction: MICA/MICB in innate immunity, adaptive immunity, autoimmunity, cancer, and in the immune response to transplants. Hum Immunol 67 (2006) 141-144
46. Sumitran-Holgersson S., Wilczek H.E., Holgersson J., and Söderström K. Identification of the nonclassical HLA molecules, MICA, as targets for humoral immunity associated with irreversible rejection of kidney allografts. Transplantation 74 (2002) 268-277. This study shows a clear clinical correlation between the presence of preformed MICA antibodies and early immunological complications in the absence of donor-specific HLA antibodies.
47. Zou Y., Stastny P., Süsal C., Döhler B., and Opelz G. Antibodies against MICA antigens and kidney-transplant rejection. N Engl J Med 357 (2007) 1293-1300. A large study reporting the association of MICA antibodies with increased graft loss among recipients well matched for HLA.
48. Terasaki P.I., Ozawa M., and Castro R. Four-year follow-up of a prospective trial of HLA and MICA antibodies on kidney graft survival. Am J Transplant 7 (2007) 408-415. Report from two prospective trials, after 1 and 4 years, providing evidence that HLA and MICA antibodies are associated with graft failure.
49. Ozawa M, Terasaki PI, Castro R, Alberu J, Morales-Buenrostro L, Alvarez I, Toledo R, Alvez H, Monteiro M, Teixeira J et al: 14th International HLA and Immunogenetics Workshop: report on the Prospective Chronic Rejection Project. Tissue Antigens 2007, 69 (Suppl. 1):174-179.
50. Suárez-Alvarez B., López-Vázquez A., Gonzalez M.Z., Fdez-Morera J.L., Díaz-Molina B., Blanco-GelazF M.A., Pascual D., Martínez-Borra J., Muro M., Alvarez-López M.R., and López-Larrea C. The relationship of anti-MICA antibodies and MICA expression with heart allograft rejection. Am J Transplant 7 (2007) 1842-1848
51. Jager M.J., Claas F.H., D'Amaro J., Baldwin W.M., and van Rood J.J. Two alloantigens on human monocytes: a diallelic system?. Hum Immunol 19 (1987) 215-224
52. Feucht H.E. Complement C4d in graft capillaries - the missing link in the recognition of humoral alloreactivity. Am J Transplant 3 (2003) 646
53. Ehrnfelt C., Serrander L., and Holgersson J. Increased adhesion under flow of human neutrophils to porcine endothelium activated by anti-α-Gal antibody binding. Transplantation 76 (2003) 1112-1119. The authors show that anti-Gal independently of complement can trigger porcine endothelium to express adhesion molecules, IL-8 and platelet activating factor, leading to increased neutrophil adhesion under conditions of flow.
54. Hauzenberger E., Klominek J., and Holgersson J. Anti-Gal IgG potentiates natural killer cell migration across porcine endothelium via endothelial cell activation and increased natural killer cell motility triggered by CD16 cross-linking. Eur J Immunol 34 (2004) 1154-1163
55. Gollackner B., Goh S.K., Qawi I., Buhler L., Knosalla C., Daniel S., Kaczmarek E., Awwad M., Cooper D.K., and Robson S.C. Acute vascular rejection of xenografts: roles of natural and elicited xenoreactive antibodies in activation of vascular endothelial cells and induction of procoagulant activity. Transplantation 77 (2004) 1735-1741
56. Xu B., Broome U., Uzunel M., Nava S., Ge X., Kumagai-Braesch M., Hultenby K., Christensson B., Ericzon B.G., Holgersson J., and Sumitran-Holgersson S. Capillarization of hepatic sinusoid by liver endothelial cell-reactive autoantibodies in patients with cirrhosis and chronic hepatitis. Am J Pathol 163 (2003) 1275-1289. This study demonstrates the ability of non-HLA Abs to transform sinusoidal endothelium into vascular endothelium. It shows that transformation is important for disease progression and explains some of the pathological hallmarks of the cirrhotic liver.
57. Le Bail B., Bioulac-Sage P., Senuita R., et al. Fine structure of hepatic sinusoids and sinusoidal cells in disease. J Electron Microsc Technol 14 (1990) 257-282
58. Le Bas-Bernardet S., Hourmant M., Coupel S., Bignon J.D., Soulillou J.P., and Charreau B. Non-HLA-type endothelial cell reactive alloantibodies in pre-transplant sera of kidney recipients trigger apoptosis. Am J Transplant 3 (2003) 167-177. This study demonstrates that one important mechanism by which non-HLA Abs decreases in vitro EC viability is by promoting EC apoptosis.